$HDSN
HUDSON TECHNOLOGIES INC /NY

2022 Q3 Form 10-Q Financial Statement

#000141057822002134 Filed on August 08, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $89.50M $103.9M $84.34M
YoY Change 47.58% 71.67% 149.67%
Cost Of Revenue $45.26M $46.44M $38.52M
YoY Change 22.44% 19.95% 56.32%
Gross Profit $44.24M $57.50M $45.82M
YoY Change 86.84% 163.41% 401.42%
Gross Profit Margin 49.43% 55.32% 54.33%
Selling, General & Admin $7.219M $7.014M $6.824M
YoY Change 18.89% 3.67% 1.13%
% of Gross Profit 16.32% 12.2% 14.89%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $698.0K $1.488M $937.0K
YoY Change -54.79% -3.44% 10.63%
% of Gross Profit 1.58% 2.59% 2.04%
Operating Expenses $7.917M $7.713M $7.522M
YoY Change 16.94% 3.32% 1.02%
Operating Profit $36.32M $49.78M $38.30M
YoY Change 114.82% 246.61% 2163.48%
Interest Expense -$2.365M $2.623M $7.305M
YoY Change -16.81% -8.67% 159.32%
% of Operating Profit -6.51% 5.27% 19.07%
Other Income/Expense, Net $0.00 -$2.623M
YoY Change -8.83%
Pretax Income $33.96M $47.16M $30.99M
YoY Change 105.3% 310.6% -2854.93%
Income Tax $4.601M $7.351M $1.438M
% Of Pretax Income 13.55% 15.59% 4.64%
Net Earnings $29.36M $39.81M $29.56M
YoY Change 84.98% 253.02% -2846.75%
Net Earnings / Revenue 32.8% 38.3% 35.04%
Basic Earnings Per Share $0.65 $0.89 $0.66
Diluted Earnings Per Share $622.2K $0.84 $0.63
COMMON SHARES
Basic Shares Outstanding 45.02M 44.96M 44.78M
Diluted Shares Outstanding 47.18M 47.15M 46.74M

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $15.05M $20.68M $5.152M
YoY Change 58.36% 1004.22% 84.0%
Cash & Equivalents $15.05M $20.68M $5.152M
Short-Term Investments
Other Short-Term Assets $18.74M $7.205M $7.680M
YoY Change 70.44% -35.59% 2.4%
Inventory $120.2M $118.7M $101.3M
Prepaid Expenses
Receivables $38.67M $43.74M $38.18M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $192.6M $190.3M $152.3M
YoY Change 89.92% 101.11% 112.15%
LONG-TERM ASSETS
Property, Plant & Equipment $27.11M $19.19M $19.18M
YoY Change 35.3% -7.01% -29.99%
Goodwill $47.80M $47.80M
YoY Change 0.0%
Intangibles $18.96M $19.66M
YoY Change -12.84%
Long-Term Investments
YoY Change
Other Assets $762.0K $690.0K $705.0K
YoY Change 350.89% 119.75% 605.0%
Total Long-Term Assets $93.93M $94.43M $94.52M
YoY Change -1.86% -1.69% -3.26%
TOTAL ASSETS
Total Short-Term Assets $192.6M $190.3M $152.3M
Total Long-Term Assets $93.93M $94.43M $94.52M
Total Assets $286.6M $284.7M $246.8M
YoY Change 45.36% 49.32% 45.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $14.89M $13.88M $8.623M
YoY Change 122.37% 55.29% -4.19%
Accrued Expenses $39.93M $38.62M $33.99M
YoY Change 107.58% 32.27% 57.34%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Long-Term Debt Due $4.250M $4.250M $4.250M
YoY Change -19.02% -44.98% -75.99%
Total Short-Term Liabilities $59.07M $56.74M $46.86M
YoY Change 16.33% -5.2% -2.98%
LONG-TERM LIABILITIES
Long-Term Debt $49.83M $80.68M $91.53M
YoY Change -32.89% 7.07% 19.64%
Other Long-Term Liabilities $6.178M $6.283M $5.819M
YoY Change 69.96% 123.67% 71.15%
Total Long-Term Liabilities $56.01M $80.68M $91.53M
YoY Change -24.56% 7.07% 14.55%
TOTAL LIABILITIES
Total Short-Term Liabilities $59.07M $56.74M $46.86M
Total Long-Term Liabilities $56.01M $80.68M $91.53M
Total Liabilities $116.0M $143.8M $145.9M
YoY Change -10.93% 3.09% 12.61%
SHAREHOLDERS EQUITY
Retained Earnings $23.54M -$16.27M
YoY Change -134.69%
Common Stock $450.0K $449.0K
YoY Change 2.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $170.6M $140.9M $100.9M
YoY Change
Total Liabilities & Shareholders Equity $286.6M $284.7M $246.8M
YoY Change 45.36% 49.32% 45.63%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income $29.36M $39.81M $29.56M
YoY Change 84.98% 253.02% -2846.75%
Depreciation, Depletion And Amortization $698.0K $1.488M $937.0K
YoY Change -54.79% -3.44% 10.63%
Cash From Operating Activities $26.15M $28.80M $5.066M
YoY Change 58.92% -932.4% -201.95%
INVESTING ACTIVITIES
Capital Expenditures -$895.0K -$793.0K $27.00K
YoY Change 262.35% 519.53% -90.69%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$895.0K -$793.0K -$27.00K
YoY Change 262.35% 519.53% -90.69%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $71.00K
YoY Change
Debt Paid & Issued, Net $79.87M
YoY Change 5978.08%
Cash From Financing Activities -30.89M -12.48M -3.379M
YoY Change 260.11% -565.08% -150.54%
NET CHANGE
Cash From Operating Activities 26.15M 28.80M 5.066M
Cash From Investing Activities -895.0K -793.0K -27.00K
Cash From Financing Activities -30.89M -12.48M -3.379M
Net Change In Cash -5.633M 15.53M 1.660M
YoY Change -173.83% -1816.02% 16.33%
FREE CASH FLOW
Cash From Operating Activities $26.15M $28.80M $5.066M
Capital Expenditures -$895.0K -$793.0K $27.00K
Free Cash Flow $27.04M $29.59M $5.039M
YoY Change 61.93% -988.18% -195.82%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Address State Or Province
EntityAddressStateOrProvince
NJ
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
07677
dei City Area Code
CityAreaCode
845
CY2022Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q2 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
dei Entity Registrant Name
EntityRegistrantName
HUDSON TECHNOLOGIES INC /NY
dei Entity Central Index Key
EntityCentralIndexKey
0000925528
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Amendment Flag
AmendmentFlag
false
CY2022Q2 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2022#AccruedLiabilitiesAndOtherLiabilities
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44758925
CY2022Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
45020087
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-13412
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
13-3641539
dei Entity Address Address Line1
EntityAddressAddressLine1
300 Tice Boulevard
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 290
dei Entity Address City Or Town
EntityAddressCityOrTown
Woodcliff Lake
dei Local Phone Number
LocalPhoneNumber
735-6000
dei Security12b Title
Security12bTitle
Common stock, $0.01 par value
dei Trading Symbol
TradingSymbol
HDSN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44758925
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
450000
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
45020087
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
448000
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
20682000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3492000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
45020087
CY2022Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
43744000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
14223000
CY2022Q2 us-gaap Inventory Net
InventoryNet
118664000
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2022Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
7205000
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
8090000
CY2022Q2 us-gaap Assets Current
AssetsCurrent
190295000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
119949000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19187000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
CY2022Q2 us-gaap Goodwill
Goodwill
47803000
CY2021Q4 us-gaap Goodwill
Goodwill
47803000
CY2022Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
18960000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
20357000
CY2022Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
7794000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
6803000
CY2022Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
690000
CY2021Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
710000
CY2022Q2 us-gaap Assets
Assets
284729000
CY2021Q4 us-gaap Assets
Assets
215715000
CY2022Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
13877000
CY2021Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
9623000
CY2022Q2 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
35978000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
30637000
CY2022Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
2637000
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
3931000
CY2022Q2 us-gaap Long Term Debt Current
LongTermDebtCurrent
4250000
CY2021Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
5248000
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
15000000
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
56742000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
64439000
CY2022Q2 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
90000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
1692000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6283000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
5500000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
80677000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2022Q2 us-gaap Liabilities
Liabilities
143792000
CY2021Q4 us-gaap Liabilities
Liabilities
144776000
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000
CY2022Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116943000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
116312000
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
23544000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-45821000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
140937000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
284729000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
215715000
CY2022Q2 us-gaap Revenues
Revenues
103941000
CY2021Q2 us-gaap Revenues
Revenues
60548000
us-gaap Revenues
Revenues
188279000
us-gaap Revenues
Revenues
94328000
CY2022Q2 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
46444000
CY2021Q2 hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
38720000
hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
84962000
hdsn Cost Of Sales Excluding Cost Of Net Realizable Value Adjustment
CostOfSalesExcludingCostOfNetRealizableValueAdjustment
63362000
CY2022Q2 us-gaap Gross Profit
GrossProfit
57497000
CY2021Q2 us-gaap Gross Profit
GrossProfit
21828000
us-gaap Gross Profit
GrossProfit
103317000
us-gaap Gross Profit
GrossProfit
30966000
CY2022Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7014000
CY2021Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6766000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13838000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
13514000
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
699000
CY2021Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
699000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1397000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
1397000
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
7713000
CY2021Q2 us-gaap Operating Expenses
OperatingExpenses
7465000
us-gaap Operating Expenses
OperatingExpenses
15235000
us-gaap Operating Expenses
OperatingExpenses
14911000
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
49784000
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
14363000
us-gaap Operating Income Loss
OperatingIncomeLoss
88082000
us-gaap Operating Income Loss
OperatingIncomeLoss
16055000
CY2022Q2 us-gaap Interest Expense
InterestExpense
2623000
CY2021Q2 us-gaap Interest Expense
InterestExpense
2872000
us-gaap Interest Expense
InterestExpense
9928000
us-gaap Interest Expense
InterestExpense
5689000
CY2021Q2 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
5000
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2623000
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2877000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9928000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5694000
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
47161000
CY2021Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11486000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
78154000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10361000
CY2022Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
7351000
CY2021Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
209000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8789000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
160000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39810000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
11277000
us-gaap Net Income Loss
NetIncomeLoss
69365000
us-gaap Net Income Loss
NetIncomeLoss
10201000
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
CY2021Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.55
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.23
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.84
CY2021Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.24
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.48
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.22
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44960464
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43498908
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44870642
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43426463
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47152257
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46418807
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46974441
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45844545
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
39908000
CY2021Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
3000
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
9000
CY2021Q2 us-gaap Profit Loss
ProfitLoss
11277000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
51197000
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
100896000
CY2022Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
52000
CY2022Q2 hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
1000
CY2022Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
180000
CY2022Q2 us-gaap Profit Loss
ProfitLoss
39810000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
140937000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
40622000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
370000
us-gaap Profit Loss
ProfitLoss
10201000
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
51197000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
70939000
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
123000
hdsn Adjustments To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentsToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
73000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
583000
us-gaap Profit Loss
ProfitLoss
69365000
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
140937000
us-gaap Net Income Loss
NetIncomeLoss
69365000
us-gaap Net Income Loss
NetIncomeLoss
10201000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1726000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1694000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1397000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1397000
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-1155000
hdsn Lower Of Cost Or Net Realizable Value Adjustment
LowerOfCostOrNetRealizableValueAdjustment
-1752000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
1207000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
53000
us-gaap Share Based Compensation
ShareBasedCompensation
583000
us-gaap Share Based Compensation
ShareBasedCompensation
370000
hdsn Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
2004000
hdsn Amortization Of Deferred Financing Costs
AmortizationOfDeferredFinancingCosts
558000
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-4665000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1602000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
117000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
30727000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
23562000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23366000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
2039000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1677000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
5031000
hdsn Increase Decrease In Lease Obligations
IncreaseDecreaseInLeaseObligations
15000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-429000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
8078000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9135000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
33867000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8430000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
820000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
418000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-820000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-418000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
123000
hdsn Excess Tax Benefits From Share Based Compensation Financing Activities
ExcessTaxBenefitsFromShareBasedCompensationFinancingActivities
-73000
us-gaap Payments Of Merger Related Costs Financing Activities
PaymentsOfMergerRelatedCostsFinancingActivities
8512000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-15000000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
12000000
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
100000000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
92395000
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
2627000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-15857000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9373000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
17190000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
525000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3492000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1348000
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
20682000
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1873000
us-gaap Interest Paid Net
InterestPaidNet
7911000
us-gaap Interest Paid Net
InterestPaidNet
5059000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
5908000
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
-278000
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
hdsn Percentage Of Stepdown From Baseline Levels Final Rule
PercentageOfStepdownFromBaselineLevelsFinalRule
0.10
hdsn Percentage Of Cumulative Reduction From Baseline Levels Subsequent Allowance
PercentageOfCumulativeReductionFromBaselineLevelsSubsequentAllowance
0.40
hdsn Allocation Allowance Received By Company
AllocationAllowanceReceivedByCompany
3000000
hdsn Allocation Allowance Received By Company As Percentage Of Hydrofluorocarbons Consumption
AllocationAllowanceReceivedByCompanyAsPercentageOfHydrofluorocarbonsConsumption
0.01
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Credit Risk</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of temporary cash investments and trade accounts receivable. The Company maintains its temporary cash investments in highly-rated financial institutions and, at times, the balances exceed FDIC insurance coverage. The Company’s trade accounts receivable are primarily due from companies throughout the United States. The Company reviews each customer’s credit history before extending credit.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company establishes an allowance for doubtful accounts based on factors associated with the credit risk of specific accounts, historical trends, and other information. The carrying value of the Company’s accounts receivable is reduced by the established allowance for doubtful accounts. The allowance for doubtful accounts includes any accounts receivable balances that are determined to be uncollectible, along with a general reserve for the remaining accounts receivable balances. The Company adjusts its reserves based on factors that affect the collectability of the accounts receivable balances.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">For the six month period ended June 30, 2022 there was no customer accounting for 10% of the Company’s revenues. For the six month period ended June 30, 2021 there was one customer accounting for 10% of the Company’s revenues and at June 30, 2021 there were $2.2 million of accounts receivable from this customer.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The loss of a principal customer or a decline in the economic prospects of and/or a reduction in purchases of the Company’s products or services by any such customer could have a material adverse effect on the Company’s operating results and financial position.</p>
CY2022Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3500000
CY2018Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11300000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
hdsn Cylinder Deposit Value
CylinderDepositValue
13500000
CY2021 hdsn Cylinder Deposit Value
CylinderDepositValue
12300000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
8800000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11600000
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.112
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11600000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
19000000.0
CY2021Q4 hdsn Net Operating Loss
NetOperatingLoss
16800000
CY2021Q4 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3900000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
15100000
CY2022Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
11600000
CY2022Q2 us-gaap Operating Loss Carryforwards Valuation Allowance
OperatingLossCarryforwardsValuationAllowance
3500000
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
39810000
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
11277000
us-gaap Net Income Loss
NetIncomeLoss
69365000
us-gaap Net Income Loss
NetIncomeLoss
10201000
CY2022Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44960464
CY2021Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43498908
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44870642
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43426463
CY2022Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2191793
CY2021Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2919899
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2103799
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2418082
CY2022Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
47152257
CY2021Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46418807
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46974441
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
45844545
CY2022Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
752
CY2021Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
30843
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1090
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
199694
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Estimates and Risks</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with generally accepted accounting principles in the United States requires the use of estimates and assumptions that affect the amounts reported in these financial statements and footnotes. The Company considers these accounting estimates to be critical in the preparation of the accompanying consolidated financial statements. The Company uses information available at the time the estimates are made. However, these estimates could change materially if different information or assumptions were used including potential impact of COVID-19 uncertainties. Additionally, these estimates may not ultimately reflect the actual amounts of the final transactions that occur. The Company utilizes both internal and external sources to evaluate potential current and future liabilities for various commitments and contingencies. In the event that the assumptions or conditions change in the future, the estimates could differ from the original estimates.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">Several of the Company’s accounting policies involve significant judgments, uncertainties and estimates. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions. To the extent that actual results differ from management’s judgments and estimates, there could be a material adverse effect on the Company. On a continuous basis, the Company evaluates its estimates, including, but not limited to, those estimates related to its allowance for doubtful accounts, inventory reserves, goodwill and valuation allowance for the deferred tax assets relating to its NOLs and commitments and contingencies. With respect to trade accounts receivable, the Company estimates the necessary allowance for doubtful accounts based on both historical and anticipated trends of payment history and the ability of the customer to fulfill its obligations. For inventory, the Company evaluates both current and anticipated sales prices of its products to determine if a write down of inventory to net realizable value is necessary. In determining the Company’s valuation allowance for its deferred tax assets, the Company assesses its ability to generate taxable income in the future.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company participates in an industry that is highly regulated, and changes in the regulations affecting its business could affect its operating results. Currently the Company purchases virgin hydrochlorofluorocarbon (“HCFC”) and hydrofluorocarbon (“HFC”) refrigerants and reclaimable, primarily HCFC, HFC and chlorofluorocarbon (“CFC”), refrigerants from suppliers and its customers. To the extent that the Company is unable to source sufficient quantities of refrigerants or is unable to obtain refrigerants on commercially reasonable terms or experiences a decline in demand and/or price for refrigerants sold by the Company, the Company could realize reductions in revenue from refrigerant sales, which could have a material adverse effect on its operating results and its financial position. The process of sourcing refrigerants includes various procurement costs, such as freight, processing, insurance, and other costs, relating to the delivery of refrigerants. As a result of the recently noted global supply chain issues, the Company determined it could be exposed to incremental costs related to these refrigerant purchases. These costs represent the Company’s initial estimate that are possibly subject to finalization in future periods and are recorded in accrued expenses and other current liabilities on the consolidated balance sheet as of June 30, 2022.</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The Company is subject to various legal proceedings. The Company assesses the merit and potential liability associated with each of these proceedings. In addition, the Company estimates potential liability, if any, related to these matters. To the extent that these estimates are not accurate, or circumstances change in the future, the Company could realize liabilities, which could have a material adverse effect on its operating results and its financial position.</p>
CY2022Q2 us-gaap Inventory Gross
InventoryGross
123194000
CY2021Q4 us-gaap Inventory Gross
InventoryGross
99828000
CY2022Q2 us-gaap Inventory Adjustments
InventoryAdjustments
4530000
CY2021Q4 us-gaap Inventory Adjustments
InventoryAdjustments
5684000
CY2022Q2 us-gaap Inventory Net
InventoryNet
118664000
CY2021Q4 us-gaap Inventory Net
InventoryNet
94144000
CY2022Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
54567000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
53854000
CY2022Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
35380000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
33761000
CY2022Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
19187000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20093000
us-gaap Depreciation
Depreciation
1700000
us-gaap Depreciation
Depreciation
1700000
CY2022Q2 us-gaap Lessee Operating Lease Term Of Contract
LesseeOperatingLeaseTermOfContract
P11Y
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
1818000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
2051000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1658000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1285000
CY2022Q2 hdsn Lessee Operating Lease Liability Payments Due After Year Three
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearThree
2916000
CY2022Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
9728000
CY2022Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1847000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7881000
CY2022Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1598000
CY2022Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
6283000
CY2022Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
7881000
CY2022Q2 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y10M13D
CY2022Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0824
us-gaap Operating Lease Payments
OperatingLeasePayments
1300000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2022Q2 us-gaap Goodwill
Goodwill
47800000
CY2021Q4 us-gaap Goodwill
Goodwill
47800000
CY2022Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2022Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
14037000
CY2022Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
18960000
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
32997000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
12640000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
20357000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1400000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
600000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
400000
CY2022Q2 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
4776228
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P2Y
CY2022Q2 hdsn Share Based Compensation Arrangement By Share Based Payment Award Options Aggregate Intrinsic Value Non Vested
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAggregateIntrinsicValueNonVested
1.10
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
354838
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
415478
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2461031
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y9M18D
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.26
CY2022Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
16000000.0
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
8900000
CY2022Q2 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
600000
CY2021Q4 hdsn Sharebased Compensation Arrangement By Sharebased Payment Award Options Aggregate Intrinsic Value Nonvested
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAggregateIntrinsicValueNonvested
0.0
CY2022Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1800000
CY2021Q2 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1600000
CY2022Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0
CY2021Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
15000000
CY2022Q2 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
4250000
CY2021Q4 hdsn Longterm Debt Current Net Of Other Debt
LongtermDebtCurrentNetOfOtherDebt
5248000
CY2022Q2 us-gaap Debt Current
DebtCurrent
4250000
CY2021Q4 us-gaap Debt Current
DebtCurrent
20248000
CY2022Q2 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
69687000
CY2021Q4 hdsn Long Term Debt Non Current Net Of Other Debt
LongTermDebtNonCurrentNetOfOtherDebt
74618000
CY2022Q2 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
15000000
CY2021Q4 hdsn Long Term Debt First In Last Out Filo
LongTermDebtFirstInLastOutFilo
0
CY2022Q2 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4010000
CY2021Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
1473000
CY2022Q2 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
80677000
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
73145000
CY2022Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
84927000
CY2021Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
93393000
CY2022Q1 us-gaap Line Of Credit Facility Maximum Borrowing Capacity
LineOfCreditFacilityMaximumBorrowingCapacity
90000000
CY2022Q1 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.020
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Repayments Of Principal In Next Twelve Months
LongTermDebtAndCapitalLeaseObligationsRepaymentsOfPrincipalInNextTwelveMonths
4250000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Two
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearTwo
4250000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Three
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearThree
4250000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Four
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFour
4250000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal In Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalInYearFive
71937000
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations Maturities Repayments Of Principal After Year Five
LongTermDebtAndCapitalLeaseObligationsMaturitiesRepaymentsOfPrincipalAfterYearFive
0
CY2022Q2 us-gaap Long Term Debt And Capital Lease Obligations
LongTermDebtAndCapitalLeaseObligations
88937000

Files In Submission

Name View Source Status
0001410578-22-002134-index-headers.html Edgar Link pending
0001410578-22-002134-index.html Edgar Link pending
0001410578-22-002134.txt Edgar Link pending
0001410578-22-002134-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hdsn-20220630.xsd Edgar Link pending
hdsn-20220630x10q.htm Edgar Link pending
hdsn-20220630xex31d1.htm Edgar Link pending
hdsn-20220630xex31d2.htm Edgar Link pending
hdsn-20220630xex32d1.htm Edgar Link pending
hdsn-20220630xex32d2.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hdsn-20220630_cal.xml Edgar Link unprocessable
hdsn-20220630_def.xml Edgar Link unprocessable
hdsn-20220630_lab.xml Edgar Link unprocessable
hdsn-20220630_pre.xml Edgar Link unprocessable
hdsn-20220630x10q_htm.xml Edgar Link completed
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending